Spots Global Cancer Trial Database for Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
Official Title: Effectiveness and Safety of Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
Study ID: NCT02935530
Study Description
Brief Summary: Venous thromboembolism (VTE) is an important cause of post-operative morbidity and mortality in women undergoing surgery for gynecologic malignancies. Although the benefit of thromboprophylaxis in reduction of post-operative VTE events after surgery for gynecologic cancers has been well documented around the world, the evidence for Chinese women is rare. The investigators designed this prospective and randomized study to assess the benefit of pharmacologic prophylaxis for patients received surgical treatment for gynecologic malignancies in China.
Detailed Description:
Keywords
Eligibility
Minimum Age: 16 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Tongji Hospital, Wuhan, Hubei, China
Contact Details
Name: Ding Ma, M.D.
Affiliation: Tongji Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
